United Therapeutics buy UBS Group AG
Start price
13.08.25
/
50%
€258.80
Target price
13.08.26
€355.41
Performance (%)
62.67%
Price
12.12.25
€421.00
Summary
This prediction is currently active. With a performance of 62.67% the BUY prediction by UBS_Group_AG is a big success. This prediction currently runs until 13.08.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| United Therapeutics | 1.226% | 1.226% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by UBS_Group_AG for this prediction
In the thread United Therapeutics diskutieren
United Therapeutics Corporation (NASDAQ: UTHR) had its price target raised by analysts at UBS Group AG from $385.00 to $415.00. They now have a "buy" rating on the stock.
Ratings data for UTHR provided by MarketBeat
Stopped prediction by UBS_Group_AG for United Therapeutics
United Therapeutics
Start price
Target price
Perf. (%)
€393.20
06.11.25
06.11.25
€521.34
06.11.26
06.11.26
7.07%
12.12.25
12.12.25
United Therapeutics
Start price
Target price
Perf. (%)
€360.40
29.09.25
29.09.25
€494.80
29.09.26
29.09.26
16.81%
12.12.25
12.12.25
United Therapeutics
Start price
Target price
Perf. (%)
€337.60
04.09.25
04.09.25
€480.20
04.09.26
04.09.26
24.70%
12.12.25
12.12.25
United Therapeutics
Start price
Target price
Perf. (%)
€244.10
30.06.25
30.06.25
€328.48
30.06.26
30.06.26
72.47%
12.12.25
12.12.25
United Therapeutics
Start price
Target price
Perf. (%)
€355.30
08.01.25
08.01.25
€460.94
08.01.26
08.01.26
18.49%
12.12.25
12.12.25
United Therapeutics
Start price
Target price
Perf. (%)
€292.80
08.07.24
08.07.24
€341.51
08.07.25
08.07.25
-14.82%
09.07.25
09.07.25